Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: Active and passive immunization

Clinics in Perinatology

Volumn 37, Issue 4, 2010, Pages 787-805

  Lohman Payne, Barb ^a,b   Slyker, Jennifer ^b,c   Rowland Jones, Sarah L ^c  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cofactor; HIV 1; Infant; Vaccine

Indexed keywords

ACICLOVIR; BCG VACCINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; METRONIDAZOLE; NEUTRALIZING ANTIBODY; NEVIRAPINE; PLACEBO; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VALACICLOVIR; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; BLOOD PLACENTA BARRIER; BREAST FEEDING; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; HELMINTHIASIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; MALARIA; MIXED INFECTION; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SEROPREVALENCE; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE DRUG DOSE; VAGINITIS; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

CLINICAL TRIALS AS TOPIC; DRUG INDUSTRY; FEMALE; HELMINTHIASIS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALARIA; PREGNANCY; VACCINATION; VAGINOSIS, BACTERIAL; VIRAL VACCINES;

EID: 78349286286     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.08.005     Document Type: Review

References (147)

1. Obimbo E.M., Mbori-Ngacha D.A., Ochieng J.O., et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J 2004, 23(6):536-543.
2. Newell M.L., Coovadia H., Cortina-Borja M., et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364(9441):1236-1243.
3. Richardson B.A., Mbori-Ngacha D., Lavreys L., et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol 2003, 77(12):7120-7123.
4. Mphatswe W., Blanckenberg N., Tudor-Williams G., et al. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS 2007, 21(10):1253-1261.
5. Lohman B.L., Slyker J.A., Richardson B.A., et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol 2005, 79(13):8121-8130.
6. Miles D.J., van der Sande M., Jeffries D., et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol 2007, 81(11):5766-5776.
7. Slyker J.A., Lohman-Payne B.L., John-Stewart G.C., et al. Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS 2009, 23(16):2173-2181.
8. Maury W., Potts B.J., Rabson A.B. HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission. J Infect Dis 1989, 160(4):583-588.
9. John-Stewart G.C., Mbori-Ngacha D., Payne B.L., et al. HIV-1-Specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. J Infect Dis 2009, 199(6):889-898.
10. Mussi-Pinhata M.M., Freimanis L., Yamamoto A.Y., et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 2007, 119(3):e694-e704.
11. Kuhn L., Kasonde P., Sinkala M., et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?. Clin Infect Dis 2005, 41(11):1654-1661.
12. Slogrove A.L., Cotton M.F., Esser M.M. Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency. J Trop Pediatr 2010, 56(2):75-81.
13. Lehman D.A., Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 2007, 17(6):381-403.
14. John G.C., Nduati R.W., Mbori-Ngacha D.A., et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001, 183(2):206-212.
15. Becquet R., Bland R., Leroy V., et al. Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts. PLoS One 2009, 4:e3797.
16. John-Stewart G., Mbori-Ngacha D., Ekpini R., et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr 2004, 35(2):196-202.
17. Dolcini G., Derrien M., Chaouat G., et al. Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5. AIDS Res Hum Retroviruses 2003, 19(10):857-864.
18. Lagaye S., Derrien M., Menu E., et al. Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 2001, 75(10):4780-4791.
19. Cheynier R., Langlade-Demoyen P., Marescot M.R., et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1-infected mothers. Eur J Immunol 1992, 22:2211-2217.
20. Rowland-Jones S.L., Nixon D.F., Aldhous M.C., et al. HIV-specific CTL activity in an HIV-exposed but uninfected infant. Lancet 1993, 341:860-861.
21. Aldhous M.C., Watret K.C., Mok J.Y., et al. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol 1994, 97(1):61-67.
22. Kuhn L., Coutsoudis A., Moodley D., et al. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission. AIDS 2001, 15(1):1-9.
23. Pitisuttithum P., Gilbert P., Gurwith M., et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 2006, 194(12):1661-1671.
24. Buchbinder S.P., Mehrotra D.V., Duerr A., et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008, 372(9653):1881-1893.
25. McElrath M.J., De Rosa S.C., Moodie Z., et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008, 372(9653):1894-1905.
26. Liu J., O'Brien K.L., Lynch D.M., et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009, 457(7225):87-91.
27. Hansen S.G., Vieville C., Whizin N., et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 2009, 15(3):293-299.
28. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361(23):2209-2220.
29. Abel K., Pahar B., Van Rompay K.K., et al. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J Virol 2006, 80:6357-6367.
30. Kumar R.B., Maher D.M., Herzberg M.C., et al. Expression of HIV receptors, alternate receptors and co-receptors on tonsillar epithelium: implications for HIV binding and primary oral infection. J Virol 2006, 3:25-38.
31. Azizi A., Ghunaim H., Diaz-Mitoma F., et al. Mucosal HIV vaccines: a holy grail or a dud?. Vaccine 2010, 28:4015-4026.
32. Wright P.F., Mestecky J., McElrath M.J., et al. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis 2004, 189:1221-1231.
33. Kotton C.N., Lankowski A.J., Scott N., et al. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 gag antigen via the Salmonella Type III secretion system. Vaccine 2006, 24:6216-6224.
34. Jaspan H.B., Lawn S.D., Safrit J.T., et al. The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS 2006, 20:483-494.
35. Marchant A., Newport M. Prevention of infectious diseases by neonatal and early infantile immunization: prospects for the new millennium. Curr Opin Infect Dis 2000, 13:241-246.
36. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nature Rev 2004, 4:553-564.
37. Levy O. Innate immunity of HTE newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-389.
38. Velilla P.A., Rugeles M.T., Chougnet C.A. Defective antigen-resenting cell function in human neonates. Clin Immunol 2006, 121:251-259.
39. Chheda S., Palkowetz K.H., Garofalo R., et al. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor - [alpha] and its receptors. Pediatr Res 1996, 40:475-483.
40. Lilic D., Cant A.J., Abinun M., et al. Cytokine production differs in children and adults. Pediatr Res 1997, 42:237-240.
41. Marchant A., Goetghebuer T., Ota M.O., et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999, 163:2249-2255.
42. Ota M.O., Vekemans J., Schlegel-Haueter S.E., et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002, 168(2):919-925.
43. Godfrey W.R., Spoden D.J., Ge Y.G., et al. Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005, 105:750-758.
44. Legrand F.A., Nixon D.F., Loo C.P., et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One 2006, 1:e102.
45. Hartigan-O'Connor D.J., Abel K., McCune J.M. Suppression of SIV-specific CD4+ T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression. J Exp Med 2007, 204:2679-2692.
46. Mold J.E., Michaelsson J., Burt T.D., et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008, 322(5907):1562-1565.
47. Flanagan K.L., Halliday A., Burl S., et al. The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth. Eur J Immunol 2010, 40(4):1062-1072.
48. Gans H., Yasukawa L., Rinki M., et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001, 184:817-826.
49. Van Rompay K.K.A., Otsyula M.G., Tarara R.P., et al. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J Infect Dis 1996, 173:1327-1335.
50. Van Rompay K.K., Berardi C.J., Dillard-Telm S., et al. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 1998, 177:1247-1259.
51. Hofmann-Lehmann R., Vlasak J., Rasmussen R.A., et al. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol 2001, 75:7470-7480.
52. Ferrantelli F., Rasmussen R.A., Buckley K.A., et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis 2004, 189:2149-2153.
53. Ferrantelli F., Buckley K.A., Rasmussen R.A., et al. Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. Virology 2007, 358:69-78.
54. Van Rompay K.K., Greenier J.L., Cole K.S., et al. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol 2003, 77:179-190.
55. Van Rompay K.K., Abel K., Lawson J.R., et al. Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr 2005, 38:124-134.
56. Cristillo A.D., Lisziewicz J., He L., et al. HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3. Virology 2007, 366:197-211.
57. McFarland E.J., Johnson D.C., Muresan P., et al. HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers. AIDS 2006, 20(11):1481-1489.
58. Johnson D.C., McFarland E.J., Muresan P., et al. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. J Infect Dis 2005, 192:2129-2133.
59. Gray R.H., Wawer M.J., Brookmeyer R., et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357(9263):1149-1153.
60. Corey L., Wald A., Celum C.L., et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004, 35(5):435-445.
61. Hitti J., Watts D.H., Burchett S.K., et al. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997, 177(2):450-454.
62. Freeman E.E., Weiss H.A., Glynn J.R., et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20(1):73-83.
63. Cowan F.M., Humphrey J.H., Ntozini R., et al. Maternal herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study. AIDS 2008, 22(2):193-201.
64. Bollen L.J., Whitehead S.J., Mock P.A., et al. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?. AIDS 2008, 22(10):1169-1176.
65. Chen K.T., Tuomala R.E., Chu C., et al. No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol 2008, 198(4):399. e1-395.
66. Drake A.L., John-Stewart G.C., Wald A., et al. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission. Obstet Gynecol 2007, 109(2 Pt 1):403-409.
67. Schacker T., Zeh J., Hu H., et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002, 186(12):1718-1725.
68. Schacker T., Ryncarz A.J., Goddard J., et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998, 280(1):61-66.
69. Cunningham A.L., Turner R.R., Miller A.C., et al. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest 1985, 75(1):226-233.
70. Koelle D.M., Abbo H., Peck A., et al. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis 1994, 169(5):956-961.
71. Mbopi-Keou F.X., Gresenguet G., Mayaud P., et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000, 182(4):1090-1096.
72. McClelland R.S., Wang C.C., Overbaugh J., et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002, 16(18):2425-2430.
73. Mole L., Ripich S., Margolis D., et al. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997, 176(3):766-770.
74. Nagot N., Ouedraogo A., Foulongne V., et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007, 356(8):790-799.
75. Van de Perre P., Segondy M., Foulongne V., et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 2008, 8(8):490-497.
76. McMahon M.A., Siliciano J.D., Lai J., et al. The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem 2008, 283(46):31289-31293.
77. Lisco A., Vanpouille C., Tchesnokov E.P., et al. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe 2008, 4(3):260-270.
78. Celum C., Wald A., Hughes J., et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371(9630):2109-2119.
79. Celum C., Wald A., Lingappa J.R., et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010, 362(5):427-439.
80. Watson-Jones D., Weiss H.A., Rusizoka M., et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008, 358(15):1560-1571.
81. Zhu J., Hladik F., Woodward A., et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009, 15(8):886-892.
82. Kimberlin D.F., Weller S., Whitley R.J., et al. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 1998, 179(4):846-851.
83. Rowland-Jones S.L., Lohman B. Interactions between malaria and HIV infection-an emerging public health problem?. Microbes Infect 2002, 4(12):1265-1270.
84. Kublin J.G., Patnaik P., Jere C.S., et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005, 365(9455):233-240.
85. Hoffman I.F., Jere C.S., Taylor T.E., et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999, 13(4):487-494.
86. Whitworth J.A., Hewitt K.A. Effect of malaria on HIV-1 progression and transmission. Lancet 2005, 365(9455):196-197.
87. Ayouba A., Nerrienet E., Menu E., et al. Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon. Am J Trop Med Hyg 2003, 69(4):447-449.
88. Gallagher M., Malhotra I., Mungai P.L., et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005, 19(16):1849-1855.
89. Brahmbhatt H., Sullivan D., Kigozi G., et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 2008, 47(4):472-476.
90. Ayisi J.G., van Eijk A.M., Newman R.D., et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004, 10(4):643-652.
91. Naniche D., Lahuerta M., Bardaji A., et al. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria. HIV Med 2008, 9(9):757-764.
92. Brahmbhatt H., Kigozi G., Wabwire-Mangen F., et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 2003, 17(17):2539-2541.
93. Inion I., Mwanyumba F., Gaillard P., et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003, 188(11):1675-1678.
94. Mwapasa V., Rogerson S.J., Molyneux M.E., et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004, 18(7):1051-1059.
95. Moormann A.M., Sullivan A.D., Rochford R.A., et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999, 180(6):1987-1993.
96. Abrams E.T., Brown H., Chensue S.W., et al. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J Immunol 2003, 170(5):2759-2764.
97. Chaisavaneeyakorn S., Moore J.M., Mirel L., et al. Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection. Clin Diagn Lab Immunol 2003, 10(4):631-636.
98. Fried M., Muga R.O., Misore A.O., et al. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998, 160(5):2523-2530.
99. Tkachuk A.N., Moormann A.M., Poore J.A., et al. Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. J Infect Dis 2001, 183(6):967-972.
100. Fleming D.T., Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999, 75(1):3-17.
101. Wolday D., Gebremariam Z., Mohammed Z., et al. The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1. AIDS 2004, 18(5):781-785.
102. Kreiss J., Willerford D.M., Hensel M., et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994, 170(6):1597-1601.
103. John G.C., Nduati R.W., Mbori-Ngacha D., et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997, 175(1):57-62.
104. Ghys P.D., Fransen K., Diallo M.O., et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997, 11(12):F85-F93.
105. Mostad S.B., Overbaugh J., DeVange D.M., et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997, 350(9082):922-927.
106. McClelland R.S., Wang C.C., Mandaliya K., et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001, 15(1):105-110.
107. Atashili J., Poole C., Ndumbe P.M., et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008, 22(12):1493-1501.
108. Taha T.E., Hoover D.R., Dallabetta G.A., et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998, 12(13):1699-1706.
109. van de Wijgert J.H., Morrison C.S., Cornelisse P.G., et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 2008, 48(2):203-210.
110. McClelland R.S., Lavreys L., Hassan W.M., et al. Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS 2006, 20(2):269-273.
111. Farquhar C., Mbori-Ngacha D., Overbaugh J., et al. Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission. AIDS 2010, 24(1):153-155.
112. Taha T.E., Brown E.R., Hoffman I.F., et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS 2006, 20(9):1313-1321.
113. Belyhun Y., Medhin G., Amberbir A., et al. Prevalence and risk factors for soil-transmitted helminth infection in mothers and their infants in Butajira, Ethiopia: a population based study. BMC Public Health 2010, 10:21.
114. Naish S., McCarthy J., Williams G.M. Prevalence, intensity and risk factors for soil-transmitted helminth infection in a South Indian fishing village. Acta Trop 2004, 91(2):177-187.
115. Yatich N.J., Yi J., Agbenyega T., et al. Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence and risk factors. Am J Trop Med Hyg 2009, 80(6):896-901.
116. Nguyen P.H., Nguyen K.C., Nguyen T.D., et al. Intestinal helminth infections among reproductive age women in Vietnam: prevalence, co-infection and risk factors. Southeast Asian J Trop Med Public Health 2006, 37(5):865-874.
117. Ponnighaus J.M., Fine P.E., Sterne J.A., et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992, 339(8794):636-639.
118. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346(8986):1339-1345.
119. van Riet E., Hartgers F.C., Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007, 212(6):475-490.
120. Malhotra I., Mungai P., Wamachi A., et al. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999, 162(11):6843-6848.
121. Elias D., Wolday D., Akuffo H., et al. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol 2001, 123(2):219-225.
122. Cooper P.J., Chico M., Sandoval C., et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001, 69(3):1574-1580.
123. Weisman Z., Kalinkovich A., Borkow G., et al. Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds. J Acquir Immune Defic Syndr 1999, 21(2):157-163.
124. Bentwich Z., Weisman Z., Moroz C., et al. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?. Clin Exp Immunol 1996, 103(2):239-243.
125. Kalinkovich A., Weisman Z., Greenberg Z., et al. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 1998, 114(3):414-421.
126. Chenine A.L., Buckley K.A., Li P.L., et al. Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques. AIDS 2005, 19(16):1793-1797.
127. Ayash-Rashkovsky M., Chenine A.L., Steele L.N., et al. Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection. Infect Immun 2007, 75(4):1751-1756.
128. Chenine A.L., Shai-Kobiler E., Steele L.N., et al. Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure. PLoS Negl Trop Dis 2008, 2(7):e265.
129. Walson J.L., Otieno P.A., Mbuchi M., et al. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 2008, 22(13):1601-1609.
130. Kallestrup P., Zinyama R., Gomo E., et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis 2005, 192(11):1956-1961.
131. Da'dara A.A., Harn D.A. Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10. Vaccine 2010, 28(5):1310-1317.
132. Actor J.K., Shirai M., Kullberg M.C., et al. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A 1993, 90(3):948-952.
133. Ayash-Rashkovsky M., Weisman Z., Diveley J., et al. Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via immunostimulatory [correction of imunostimulatory] oligonucleotides-relevance to AIDS vaccines in developing countries. Vaccine 2002, 20(21-22):2684-2692.
134. Ayash-Rashkovsky M., Weisman Z., Zlotnikov S., et al. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile. Biochem Biophys Res Commun 2001, 282(5):1169-1176.
135. Kusakabe K., Xin K.Q., Katoh H., et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol 2000, 164(6):3102-3111.
136. Wille-Reece U., Flynn B.J., Lore K., et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A 2005, 102(42):15190-15194.
137. Sieling P.A., Chung W., Duong B.T., et al. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol 2003, 170(1):194-200.
138. Lalvani A., Brookes R., Wilkinson R.J., et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 1998, 95(1):270-275.
139. Maino V.C., Maecker H.T. Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens. Clin Immunol 2003, 110:222-231.
140. DeVange Panteleeff D., John G.C., Nduati R., et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999, 37:350-353.
141. Selin L.K., Lin M.-L., Kraemer K.A., et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 1999, 11:733-742.
142. Vidor E. The nature and consequences of intra- and inter-vaccine interference. J Comp Pathol 2007, 137(Suppl 1):S62-S66.
143. Gans H.A., Arvin A.M., Galinus J., et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at 6 months of age. JAMA 1998, 280:527-532.
144. Siegrist C.A., Cordova M., Brandt C., et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998, 16:1409-1414.
145. Stoiber H. Complement, Fc receptors and antibodies: a Trojan horse in HIV infection?. Curr Opin HIV AIDS 2009, 4:394-399.
146. Shinefield H.R. Overview of the development and current use of CRM197 conjugate vaccines for pediatric use. Vaccine 2010, 28:4335-4339.
147. Baba T.W., Liska V., Khimani A.H., et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 1999, 5:194-203.